Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

valproic acid

valproic acid
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Depakene CAPSULE, ORAL 250 mg      
Stavzor DELAYED RELEASE CAPSULE, ORAL 125 mg, 250 mg, 500 mg    
Depacon, Valproate Sodium SOLUTION, INTRAVENOUS 100 mg/mL      
Depakene SYRUP, ORAL 250 mg/5 mL      
VIEW MORE Anticonvulsants, Miscellaneous
CLASS
281292
Comments:

ORDERED FORMULATION

FORMULARY INTERCHANGE

valproic acid (Stavzor)

  • 125 mg delayed release oral capsule
  • 250 mg delayed release oral capsule
  • 500 mg delayed release oral capsule

divalproex sodium (Depakote)

  • 125 mg delayed release oral tablet
  • 250 mg delayed release oral tablet
  • 500 mg delayed release oral tablet

Depakene medication guide

Stavzor medication guide

STAVZOR is a delayed-release valproic acid product similar to DEPAKOTE delayed-release and its generics. It is classified as non-formulary, not stocked. Interchange to a generic DEPAKOTE product on a mg:mg basis.

Reviewed: June 24, 2008 (STAVZOR)

Last updated: Jun. 28, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved